Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma

Virchows Archiv

Volumn 461, Issue 6, 2012, Pages 677-685

  Munari, Enrico ^a   Rinaldi, Marianna ^b   Ambrosetti, Achille ^b   Bonifacio, Massimiliano ^b   Bonalumi, Angela ^b   Chilosi, Marco ^a   Zamò, Alberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Differential diagnosis; Immunohistochemistry; Splenic marginal zone lymphoma; TCL1A

Indexed keywords

ONCOPROTEIN; TCL1A PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; MANTLE CELL LYMPHOMA; NODAL MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENIC MARGINAL ZONE LYMPHOMA; WALDENSTROEM MACROGLOBULINEMIA;

HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, NON-HODGKIN; PROTO-ONCOGENE PROTEINS; SPLENIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871486256     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1322-z     Document Type: Article

References (27)

1. Iannitto E, Minardi V, Callea V, Stelitano C, Calvaruso G, Tripodo C, Quintini G, De Cantis S, Ambrosetti A, Pizzolo G, Franco V, Florena AM, Abbadessa V (2006) Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. Eur J Haematol 76(2):134-140. doi:10.1111/j.1600-0609.2005.00578.x
2. Thieblemont C, Davi F, Noguera ME, Briere J (2011) Non-MALT marginal zone lymphoma. Curr Opin Hematol 18(4):273-279. doi:10.1097/MOH.0b013e3283477815
3. Andersen CL, Gruszka-Westwood A, Ostergaard M, Koch J, Jacobsen E, Kjeldsen E, Nielsen B (2004) A narrow deletion of 7q is common to HCL, and SMZL, but not CLL. Eur J Haematol 72(6):390-402. doi:10.1111/j.1600-0609.2004.00243.x
4. Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Papadaki T, Remstein ED, Salar A, Sole F, Stamatopoulos K, Thieblemont C, Traverse-Glehen A, Wotherspoon A, Coiffier B, Piris MA (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22(3):487-495. doi:10.1038/sj.leu.2405068
5. Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A, Falcinelli F, Piccioli M, Paulli M, Gambacorta M, Ponzoni M, Tiacci E, Ascani S, Martelli MP, Favera RD, Stein H, Pileri SA (2012) IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathol-ogy. doi:10.1111/j.1365-2559.2012.04289.x
6. Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G, Droetto S, Galletti BV, Gambacorta M, Orazi A, Pasqualucci L, Miller I, Kuppers R, Dalla-Favera R, Cattoretti G (2003) Expression of the IRTA1 receptor identifies intraepithelial and subepithe-lial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 102(10):3684-3692. doi:10.1182/blood-2003-03-0750
7. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R (2002) IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 99(8):2662-2669
8. Kanellis G, Roncador G, Arribas A, Mollejo M, Montes-Moreno S, Maestre L, Campos-Martin Y, Rios Gonzalez JL, Martinez-Torrecuadrada JL, Sanchez-Verde L, Pajares R, Cigudosa JC, Martin MC, Piris MA (2009) Identification of MNDA as a new marker for nodal marginal zone lymphoma. Leukemia 23 (10):1847-1857. doi:10.1038/leu.2009.108
9. Herling M, Patel KA, Hsi ED, Chang KC, Rassidakis GZ, Ford R, Jones D (2007) TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage. Am J Surg Pathol 31(7):1123-1129. doi:10.1097/PAS.0b013e31802e2201
10. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S, Russo G, Tsichlis P, Croce CM (2000) Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A 97(7):3028-3033. doi:10.1073/pnas.040557697
11. Laine J, Kunstle G, Obata T, Sha M, Noguchi M (2000) The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 6 (2):395-407
12. Croce CM (1999) Role of TCL1 and ALL1 in human leukemias and development. Cancer Res 59(7 Suppl):1778s-1783s
13. Isobe M, Russo G, Haluska FG, Croce CM (1988) Cloning of the gene encoding the delta subunit of the human T-cell receptor reveals its physical organization within the alpha-subunit locus and its involvement in chromosome translocations in T-cell malignancy. Proc Natl Acad Sci U S A 85 (11):3933-3937
14. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, Russo G, Hardy RR, Croce CM (2002) Human chronic lympho-cytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 99(10):6955-6960. doi:10.1073/pnas.102181599. 99/10/6955 [pii]
15. Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, Calaminici M, Campo E, Ott G, Hernandez L, Rosenwald A (2011) MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. Blood 118 (20):5550-5558. doi:10.1182/blood-2011-06-361972
16. Aggarwal M, Villuendas R, Gomez G, Rodriguez-Pinilla SM, Sanchez-Beato M, Alvarez D, Martinez N, Rodriguez A, Castillo ME, Camacho FI, Montes-Moreno S, Garcia-Marco JA, Kimby E, Pisano DG, Piris MA (2009) TCL1A expression delineates biological and clinical variability in B-cell lymphoma. Mod Pathol 22 (2):206-215. doi:10.1038/modpathol.2008.148
17. Ruiz-Ballesteros E, Mollejo M, Mateo M, Algara P, Martinez P, Piris MA (2007) MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 21(12):2547-2549. doi:10.1038/sj.leu.2404853
18. Isaacson PG, Matutes E, Burke M, Catovsky D (1994) The histo-pathology of splenic lymphoma with villous lymphocytes. Blood 84(11):3828-3834
19. Mollejo M, Menarguez J, Lloret E, Sanchez A, Campo E, Algara P, Cristobal E, Sanchez E, Piris MA (1995) Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopath-ological study of 13 cases. Am J Surg Pathol 19(10):1146-1157
20. Schmid C, Kirkham N, Diss T, Isaacson PG (1992) Splenic marginal zone cell lymphoma. Am J Surg Pathol 16(5):455-466
21. Chilosi M, Zamo A, Brighenti A, Malpeli G, Montagna L, Piccoli P, Pedron S, Lestani M, Inghirami G, Scarpa A, Doglioni C, Menestrina F (2003) Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Arch 443(2):175-183. doi:10.1007/s00428-003-0857-4
22. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N, Pollan M, Sanchez-Aguilera A, Menarguez J, Campo E, Martinez P, Mateo M, Piris MA (2005) Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 106(5):1831-1838. doi:10.1182/blood-2004-10-3898
23. Kanellis G, Mollejo M, Montes-Moreno S, Rodriguez-Pinilla SM, Cigudosa JC, Algara P, Montalban C, Matutes E, Wotherspoon A, Piris MA (2010) Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica 95(7):1122-1129. doi:10.3324/haematol.2009.013714
24. Boveri E, Arcaini L, Merli M, Passamonti F, Rizzi S, Vanelli L, Rumi E, Rattotti S, Lucioni M, Picone C, Castello A, Pascutto C, Magrini U, Lazzarino M, Paulli M (2009) Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol 20 (1):129-136. doi:10.1093/annonc/mdn563
25. Herling M, Patel KA, Khalili J, Schlette E, Kobayashi R, Medeiros LJ, Jones D (2006) TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 20(2):280-285. doi:10.1038/sj.leu.2404017
26. Novara F, Arcaini L, Merli M, Passamonti F, Zibellini S, Rizzi S, Rattotti S, Rumi E, Pascutto C, Vetro A, Astori C, Boveri E, Lucioni M, Paulli M, Zuffardi O, Lazzarino M (2009) Highresolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma. Hum Pathol 40 (11):1628-1637. doi:10.1016/j.humpath.2009.01.025
27. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643-4649. doi:10.1182/blood-2005-11-4659